Currently, there are a number of clinical and molecular markers known to be predictive of prognosis in CLL that can be applied to discriminate patients that are more likely to develop a ...
Tyrosine kinase inhibitors have revolutionized treatment for patients suffering from chronic myeloid leukemia, but cost—and cost-sharing—can be a factor in determining who has access to these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback